Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03125343

Watch and Wait as Treatment for Patients With Rectal Cancer

Led by Sahlgrenska University Hospital · Updated on 2023-11-07

400

Participants Needed

2

Research Sites

621 weeks

Total Duration

On this page

Sponsors

S

Sahlgrenska University Hospital

Lead Sponsor

K

Karolinska Institutet

Collaborating Sponsor

AI-Summary

What this Trial Is About

A national cohort study with all patients scheduled for neoadjuvant treatment with (chemo)radiotherapy or short course radiotherapy with delayed surgery 6-8 weeks) for rectal cancer staged as cT4bNX/anycTanycN and cMRF+/anycTanycN and lateral lymph nodes on MRI (and patients that have been offered short course raditotherapy with delayed surgery due to various reasons). The tumours are positioned midrectal or low and are palpable with the finger. The patients offered this treatment after recommendations on their local multidisciplinary tumour board will be will be informed and offered to participate in the study. Patients scheduled for short course radiotherapy with immediate surgery cannot be included.

CONDITIONS

Official Title

Watch and Wait as Treatment for Patients With Rectal Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with palpable rectal cancer staged cT4bNX/anycTanycN with positive mesorectal fascia or lateral lymph nodes on MRI
  • Patients appropriate for 5x5 Gy radiotherapy and 6-8 weeks delay before surgery
  • Patients scheduled for neoadjuvant therapy according to the Swedish National Program for rectal cancer
  • Patients who achieve complete response after neoadjuvant treatment can enter the Watch and Wait protocol
  • Midrectal or low rectal cancers that are palpable
  • Patients receiving (chemo)radiotherapy in the neoadjuvant setting included for biopsy substudy
Not Eligible

You will not qualify if you...

  • No informed consent received
  • Rectal cancer not palpable on digital exam (10-15 cm) during rectal examination
  • Contraindications for MRI such as incompatible metallic implants or claustrophobia
  • Patients scheduled for short course radiotherapy with immediate surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Dept. of Surgery, Sahlgrenska University Hospital/Ostra

Gothenburg, Sweden, SE 416 85

Actively Recruiting

2

Karolinska Institutet

Stockholm, Sweden

Actively Recruiting

Loading map...

Research Team

E

Eva Angenete, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here